Fabry Disease Recent News
4D Molecular's Fabry Disease Candidate Shows Early Proof-Of-Concept
Amicus's Fabry Disease Medicine Gets European Approval For Use In Adolescents
Protalix Stock Is Trading Higher On Meeting Request To FDA For Fabry Disease Candidate Application
Protalix Shares Hits 52-Week Low After Adverse Event Reported In Fabry Disease Trial With PRX-102
Avrobio Plans Registration Trial With Kidney Biopsy Endpoint To Support Potential Full Approval Of Fabry Disease Gene Therapy
Protalix Stock Falls After FDA Slaps CRL For PRX-102 Application In Fabry Disease
Sigilon Therapeutics' Fabry Disease Therapy Receives Orphan Drug Designation In US
Protalix's PRX–102 Monthly Treatment Shows Benefit In Fabry Disease
Avrobio Shares Rally On Fabry Disease Gene Therapy Encouraging Benefit In Early-Stage Study
Amicus Therapeutics Building Rare Disease Treatment Strategy; Bank Of America Initiates At Buy
Amicus Therapeutics Gains 3% On Favorable EU Medicines Recommendation